Rhythm Pharmaceuticals Inc Net Asset Quality Index
Rhythm Pharmaceuticals Inc net asset quality index. Rhythm Pharmaceuticals Inc (RYTM) has a Net Asset Quality Index of 28.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $481.19 Million minus total liabilities of $342.12 Million yields net assets of $139.07 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check RYTM cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Rhythm Pharmaceuticals Inc (2012–2025)
Net asset quality index of Rhythm Pharmaceuticals Inc from 2012 to 2025. This chart shows how Rhythm Pharmaceuticals Inc's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the index stands at 28.9%, representing net assets of $139.07 Million against total assets of $481.19 Million USD. See Rhythm Pharmaceuticals Inc (RYTM) net assets for net asset value and shareholders' equity analysis.
Rhythm Pharmaceuticals Inc Net Asset Quality Index by Year (2012–2025)
Rhythm Pharmaceuticals Inc net asset quality index by year from 2012 to 2025. The table below presents the year-by-year Net Asset Quality Index for Rhythm Pharmaceuticals Inc from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Rhythm Pharmaceuticals Inc market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 28.9% | $139.07 Million | $481.19 Million | $342.12 Million | ▼ -13.0 pp |
| 2024 | 41.9% | $164.55 Million | $392.27 Million | $227.72 Million | ▼ -9.1 pp |
| 2023 | 51.0% | $169.76 Million | $332.75 Million | $162.99 Million | ▼ -18.1 pp |
| 2022 | 69.1% | $264.26 Million | $382.48 Million | $118.22 Million | ▼ -17.1 pp |
| 2021 | 86.2% | $284.15 Million | $329.52 Million | $45.37 Million | ▼ -2.8 pp |
| 2020 | 89.0% | $166.53 Million | $187.07 Million | $20.55 Million | ▼ -2.1 pp |
| 2019 | 91.1% | $281.02 Million | $308.52 Million | $27.50 Million | ▼ -3.6 pp |
| 2018 | 94.6% | $246.26 Million | $260.21 Million | $13.95 Million | ▼ -0.8 pp |
| 2017 | 95.4% | $144.79 Million | $151.74 Million | $6.95 Million | ▲ +36.3 pp |
| 2016 | 59.1% | $7.30 Million | $12.34 Million | $5.04 Million | ▼ -26.7 pp |
| 2015 | 85.9% | $32.00 Million | $37.27 Million | $5.27 Million | ▲ +270.4 pp |
| 2014 | -184.5% | $-358.00K | $194.00K | $552.00K | ▲ +131.4 pp |
| 2013 | -316.0% | $-57.46 Million | $18.19 Million | $75.65 Million | ▼ -124.2 pp |
| 2012 | -191.8% | $-36.28 Million | $18.92 Million | $55.21 Million | — |